SCHEMBL21997281

SCHEMBL21997281

CNC1CCC2(CC1)CC(c1cccc3c1n(C)c(=O)n3C1CCC(=O)NC1=O)C2

nearest known ligand 0.54

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 20/20 0.54
CRBN Q96SW2 20/20 0.54
IKZF3 Q9UKT9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22835178 0.85 DDB1 (0.51) DDB1CRBNIKZF3
SCHEMBL26351978 0.85 DDB1 (0.51) DDB1CRBNIKZF3
SCHEMBL23536487 0.85 DDB1 (0.50) DDB1CRBNIKZF3
SCHEMBL23536488 0.84 DDB1 (0.49) DDB1CRBNIKZF3
SCHEMBL23572280 0.84 DDB1 (0.49) DDB1CRBNIKZF3
SCHEMBL23536472 0.83 DDB1 (0.48) DDB1CRBNIKZF3
SCHEMBL23572115 0.83 DDB1 (0.48) DDB1CRBNIKZF3
SCHEMBL30627204 0.82 DDB1 (0.66) DDB1CRBNIKZF3
SCHEMBL25972262 0.82 DDB1 (0.66) DDB1CRBNIKZF3
SCHEMBL23536389 0.82 DDB1 (0.57) DDB1CRBNIKZF3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3886904-A1 IRAK DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2021-10-06 EP disclosed
WO-2020113233-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2020-06-04 WO disclosed